“Successful Management of Steroid-Resistant cutaneous Acute Graft-versus-Host Disease, Toxic Epidermal Necrolysis-Like, with Ruxolitinib”, Mediterr J Hematol Infect Dis, vol. 17, no. 1, p. e2025020, Feb. 2025, doi: 10.4084/MJHID.2025.020.